LYNDSEY MOLENKAMP: Open Payments
NPI 1316710809 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 55 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $920 · 2025 $1,105
Food & beverage: $1,005Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $228 |
| Astellas Pharma US Inc | 5 | $200 |
| AstraZeneca Pharmaceuticals LP | 9 | $163 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| Lilly USA, LLC | 4 | $89 |
| PFIZER INC. | 4 | $70 |
| Inspire Medical Systems, Inc. | 1 | $47 |
| SpringWorks Therapeutics, Inc. | 1 | $39 |
| Novo Nordisk Inc | 2 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $33 |
Products named: AIRSUPRA, QULIPTA, Veozah, XIFAXAN, VRAYLAR, BREZTRI, MOUNJARO, INSPIRE.
Industry payments across AZ — which companies pay providers there.
